April 26, 2021 -- Moderna has inked a new agreement with Sanofi in order to scale up U.S. manufacturing capacity for its COVID-19 vaccine.
Beginning in September, Sanofi will provide fill/finish sterile manufacturing services and supply packaging for up to 200 million doses of Moderna's COVID-19 vaccine in the U.S., according to Moderna. Sanofi will utilize manufacturing infrastructure at its location in Ridgefield, NJ.
Already have an account? Sign in Here
To access all ScienceBoard content create a free account now: